Newsfeeds - Spark Newswire

4 minute read

The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight

Today, 7:07 AM

Biotech stocks declined for the week ending Sept. 17, extending the losses from the previous week. European Society for Medical Oncology presentations, vaccine news, clinical readouts and IPOs were among the catalysts for the week.

AGTC

5 minute read

53 Biggest Movers From Friday

By Lisa Levin

Today, 7:07 AM

Gainers Innate Pharma S.A. (NASDAQ: IPHA) shares surged 47.1% to settle at $6.15 on Friday after SVB Leerink upgraded the stock from Market Perform to Outperform.

ADGI

3 minute read

35 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

Today, 7:07 AM

Gainers

ADXS

5 minute read

Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates

By Shanthi Rexaline

Today, 7:07 AM

August proved to be a mixed month for regulatory approvals, with the Food and Drug Administration approving a few, turning down a few others and delaying the remaining.

ABBV

1 minute read

Verrica Pharmaceuticals Q2 EPS $(0.35) Up From $(0.38) YoY

By Benzinga Newsdesk

Today, 7:07 AM

Verrica Pharmaceuticals (NASDAQ:VRCA) reported quarterly losses of $(0.35) per share. This is a 7.89 percent increase over losses of $(0.38) per share from the same period last year.

VRCA

2 minute read

18 Key Biopharma Catalysts To Keep An Eye On In Q3

By Shanthi Rexaline

Today, 7:07 AM

Biopharma stocks underperformed in the first half of 2021, and several of these stocks could be in for a rebound in the coming months. Needham analyst Serge Belanger highlighted companies in the firm's coverage universe that have key catalysts in the third quarter.

ACER